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Background:Microarrays of plant-derived oligosaccharides are potentially powerful tools for the high throughput discov-
ery and screening of antibodies, enzymes, and carbohydrate-binding proteins.
Results:Oligosaccharide microarrays were produced, and their utility was demonstrated in several applications.
Conclusion:A new generation of oligosaccharide microarrays will make an important contribution to plant glycomic research.
Significance:High throughput screening technology enables themore effective production of carbohydrate active enzymes and
molecular probes.
Microarrays are powerful tools for high throughput analysis,
and hundreds or thousands of molecular interactions can be
assessed simultaneously using very small amounts of analytes.
Nucleotide microarrays are well established in plant research,
but carbohydrate microarrays are much less established, and
one reason for this is a lack of suitable glycans with which to
populate arrays. Polysaccharide microarrays are relatively easy
to produce because of the ease of immobilizing large polymers
noncovalently onto a variety of microarray surfaces, but they
lack analytical resolution because polysaccharides often contain
multiple distinct carbohydrate substructures. Microarrays of
defined oligosaccharides potentially overcome this problem but
are harder to produce because oligosaccharides usually require
coupling prior to immobilization. We have assembled a library
of well characterized plant oligosaccharides produced either by
partial hydrolysis from polysaccharides or by de novo chemical
synthesis. Once coupled to protein, these neoglycoconjugates
are versatile reagents that can be printed as microarrays onto a
variety of slide types and membranes. We show that these
microarrays are suitable for the high throughput characteriza-
tion of the recognition capabilities of monoclonal antibodies,
carbohydrate-binding modules, and other oligosaccharide-
binding proteins of biological significance and also that they
have potential for the characterization of carbohydrate-active
enzymes.
Glycans are crucial for plant life and are used for storage,
defense, and signaling and as structural cell wall components
(1–6). Plant oligo- and polysaccharides are also important
components of food and feed and have numerous industrial
applications. Starch is the most common carbohydrate in the
human diet, whereas plant cell walls provide bulk materials
including timber, paper, and cloth, as well as fine chemicals,
food ingredients, and biofuel feedstocks (1, 6–8). The com-
plexity and diversity of plant polysaccharides underpin their
biological roles and many of their industrially important char-
acteristics, but also produce challenges for research and opti-
mal utilization. A detailed knowledge of the structures, func-
tions, interactions, and occurrence of plant glycans is essential
for understanding their complex contributions to plant life and
to fully exploit their commercial potential. However, unlike
proteins and nucleotides, complex carbohydrates are not read-
ily amenable to sequencing or synthesis, and existing biochem-
ical techniques for glycan analysis, although powerful, are usu-
ally low throughput (3, 9).
The development of rapid genome sequencing methods and
improvements in protein expression techniques enable the pro-
duction of large numbers of carbohydrate-active enzymes and
carbohydrate-binding proteins including carbohydrate-bind-
ing modules (CBMs).2 There has been an exponential increase
in the number of entries of these proteins in the Carbohydrate-
Active enZYmes (CAZy) database (10), but this has not been
matched by structural analysis or determination of their bio-
chemical activities (11). Similarly, monoclonal antibodies
(mAb) are immensely valuable molecular probes for carbohy-
drate research, but their usefulness is dependent on knowledge
* This work was supported by Danish Research Council grants (toW. G. T. W.)
and in part by Grant 2/0011/09 from the Scientific Grant Agency (VEGA)
(Slovakia) (to V. F.). This work was also supported by the Danish Research
Council for Strategic Research (to M. C. F. A., M. H. C., and W. G. T. W.).
□S This article contains supplemental Tables S1 and S2 and Figs. S1 and S2.
1 To whom correspondence should be addressed. Tel.: 45-35333324; E-mail:
willats@life.ku.dk.
2 The abbreviations used are: CBM, carbohydrate-bindingmodule; HTP, high
throughput; AGP, arabinogalactan protein; RGI, rhamnogalacturonan I.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 47, pp. 39429–39438, November 16, 2012
© 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
NOVEMBER 16, 2012•VOLUME 287•NUMBER 47 JOURNAL OF BIOLOGICAL CHEMISTRY 39429
 at N
ew
castle U
niversity on February 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at N
ew
castle U
niversity on February 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at N
ew
castle U
niversity on February 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at N
ew
castle U
niversity on February 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at N
ew
castle U
niversity on February 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at N
ew
castle U
niversity on February 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at N
ew
castle U
niversity on February 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at N
ew
castle U
niversity on February 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
of the epitopes they recognize (12–15). The rate-limiting step in
CBM, mAb, and enzyme production is often a lack of efficient
methods for screening their specificities. There is therefore a
clear need in plant biology for high throughput (HTP) and high
resolution techniques for the analysis of carbohydrate-active
proteins including enzymes.
Microarray technology has underpinned the development of
multiplexed assays that have revolutionized theHTP analysis of
nucleotides, proteins, and increasingly, carbohydrates (16–18).
Using microarrays, the abundance of, and interactions
between, hundreds or thousands of molecules can be assessed
simultaneously using very small amounts of analytes (16–18).
Carbohydrate microarrays were first produced in 2002, and a
variety of approaches has been developed for the printing and
immobilization of oligo- and polysaccharides (19–26). How-
ever, the representation of glycomes on these arrays is generally
far less comprehensive than is the coverage of transcriptomes/
genomes and proteomes by nucleotide and protein arrays,
respectively. The primary reason for this is the lack of facile
methods for the production of sets of homogeneous, sequence-
defined plant oligosaccharide structures (27, 28). In contrast,
partially defined polysaccharides are relatively easy to obtain,
and microarrays and enzyme-linked immunosorbent assays
(ELISAs) populatedwith such samples have shownpotential for
HTP screening (29–31). However, most plant polysaccharides
and especially those from plant cell walls are complex het-
eropolymers and, even if pure, will typically accommodate a
range of smaller oligosaccharide substructures (or epitopes),
and so, polysaccharide-based assays, whether they be microar-
rays or ELISAs, lack analytical resolution (30–32).
We have developed a new generation of glycan microarrays
for plant research based on defined oligosaccharide structures
produced either by isolation frompolysaccharides or byde novo
chemical synthesis. Once coupled to bovine serum albumin
(BSA), these neoglycoprotein sets are highly versatile, and
microarrays can be printed on a variety of slides and mem-
branes. Most of the oligosaccharides we describe here are
derived from, or based on, cell wall polysaccharides that are
among themost complex in nature and present particular chal-
lenges for HTP analysis, but we have also included starch-re-
lated oligosaccharides and novel synthesized structures.
EXPERIMENTAL PROCEDURES
Oligosaccharide Samples—Oligosaccharides were produced
either by partial enzymatic or by chemical hydrolysis of source
polysaccharides followed by fractionation and purification or
were prepared by chemical synthesis. For detailed information
on all oligosaccharide samples, see supplemental Table 1.
MALDI-TOF Analysis of Conjugation Efficiency—Analysis
was performed as described in Ref. 33.
Monoclonal Antibodies and CBMs—Previously character-
ized cell wall-directed rat monoclonal antibodies used in this
study included LM5 (34), LM6 (35), LM13 and LM16 (36),
LM10 and LM11 (37), LM15 (38), and LM21 and LM22 (39).
Novel rat monoclonal antibodies were obtained as follows.
LM23was derived subsequent to immunizationwith a complex
pectic immunogen from apple fruits, and this antibody binds to
xylosyl residue in a range of antigenic contexts including
xylogalacturonan and xylan. LM24 and LM25 were derived
subsequent to immunization with a neoglycoprotein generated
from a mixture of XXLG and XLLG xyloglucan oligosaccha-
rides (Megazyme, Bray, Ireland). LM12 was derived subse-
quently to immunization with a neoglycoprotein generated
with oligosaccharide structure 16 (see Fig. 1). In all these cases,
immunization and hybridoma isolation protocols were carried
out as described (35). CBMs were produced as described (40,
41).
BSA Conjugation Reaction—Oligosaccharides were conju-
gated to BSA essentially as described (42). Briefly, BSA was
mixedwith oligosaccharides andNaCNBH3 (Sigma-Aldrich) in
a borate buffer at pH 8. The reaction was allowed to progress at
ambient temperature for 96 h. Where necessary, conjugates
were purified from reaction mixtures using a spin column with
a 10-kDa cut off (Pall, Lund, Sweden). The conjugates were
stored in the reaction buffer at 20 °C before use and were stable
for at least 6 months whereby CN from the reducing agent
presumably acts as a preservative.
Microarray Printing—Carbohydrate microarrays were printed
using two types of microarrays robot, a pin-basedMicroGrid II
(Digilab/Genomic Solutions, Huntingdon, UK) and a piezo-
electric Sprint (Arrayjet, Roslin, UK). For printing on the
MicroGrid II, microarrays were printed using four split pins or
four solid pins (Digilab), and oligosaccharides were diluted to a
2 mg/ml and a 0.04 mg/ml concentration in deionized water
immediately before use and transferred to a 96-well microplate
for printing.Microarrays were printed at 16 °C at 35% humidity
with one deposit per spot. The same procedure was used to
print onto nitrocellulosemembrane with a pore size of 0.45m
(Whatman,Maidstone, UK), FAST Slides (Whatman) nitrocel-
lulose-coated glass slides (Schott, Mainz, Germany), and a
range of other surface-modified glass slides (Schott). For print-
ing on the Arrayjet Sprint, the Sprint microarrayer was
equipped with a 12-sample high capacity JetSpyder sample
pick-up device. Microarrays were printed at 19 °C at 55%
humidity, using six drops per spots when printing on nitrocel-
lulose membrane and two drops per spot when printing on all
glass slide types. Samples were printed in 55.2% glycerol, 44%
water, 0.8% Triton X-100, and the same slides and nitrocellu-
lose as for the MicroGrid II were used.
Microarray Probing—Arrays were blocked by incubation for
1 h in PBS (140mMNaCl, 2.7mMKCl, 10mMNa2HPO4, 1.7mM
KH2PO4, pH 7.5) containing 5% w/v low fat milk powder
(MPBS) for nitrocellulose probing, 0.05% Tween 20 for FAST
Slides, and Schott nitrocellulose-coated glass slides and 0.5 M
borate buffer containing 50 mM ethanolamine, pH 8.5, for all
other slide types. Arrays were probed for 2 h with antibodies
diluted 1/10 in PBS containing 5% w/v low fat milk powder for
nitrocellulose membrane or in PBS containing 0.05% Tween 20
for all other slide types. After washing with PBS (all microarray
types), nitrocellulose microarrays were incubated for 2 h in
either anti-rat or anti-mouse secondary antibodies conjugated
to alkaline phosphatase (Sigma, Poole, UK) diluted 1/5000 in
5% MPBS. After further washing in PBS, microarrays were
developed using a substrate containing 5-bromo-4-chloro-3-
indolylphosphate and nitro blue tetrazolium in alkaline phos-
phatase buffer (100 mMNaCl, 5 mMMgCl2, 100 mM diethanol-
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amine, pH 9.5). All glass-based slides were incubated for 2 h in
either anti-rat or anti-mouse secondary antibodies conjugated
to Alexa Fluor 555 (Invitrogen, Life Technologies Europe BV
Nærum, Denmark) and subsequently washed in PBS and then
de-ionized water.
Scanning andAnalysis—Microarrays onnitrocellulosemem-
brane were scanned using a flatbed scanner (Cannon 8800,
Søborg, Denmark) and converted to 16-bit grayscale TIFFs.
Slides were scanned using a slide scanner (GenePix 4100,
Molecular Devices, Sunnyvale, CA). The output from all scan-
ning was analyzed using microarray analysis software
(ImaGene 6.0, BioDiscovery, El Segundo, CA). Output from the
analysis was further processed as necessary using Excel
(Microsoft Denmark, Hellerup, Denmark) and presented as
heat maps in which color intensity is correlated to mean spot
signals.
Oligosaccharide Microarray Analysis of Phosphorylase
Activity—The array was blocked by incubation for 1 h in PBS
(140mMNaCl, 2.7 mMKCl, 10mMNa2HPO4, 1.7 mMKH2PO4,
pH 7.5) containing 5% w/v BSA powder. After blocking, the
arraywaswashed three times for 5minwith 100mMMOPS, pH
7.0. Following the washes, the array was probed with 1 mg/ml
rabbit muscle phosphorylase a (P1261, Sigma) and 50 kBq of
[14C]glucose 1-phosphate (GE Healthcare) for 2 h at 25 °C
under continuous shaking (25 rpm). After incubation, the array
was washed with PBS for 15 min. This was followed by a two
washes with 2 PBS with 0.05% v/v Tween 20 for each 5 min.
After this, a sample from the washing buffer was taken, and the
radioactivity was analyzed. If radioactivity was reduced to base-
line levels, themembranewas left drying and subsequently ana-
lyzed on a PhosphorImager system (445 SI, GE Healthcare).
Immunofluorescent Labeling of Tobacco Sections—The cell
wall imaging of xyloglucan mAb binding to tobacco stem pith
parenchyma cell walls pretreated with pectate lyase was per-
formed as described (38).
RESULTS
A Library of Plant Oligosaccharides—A set of oligosaccha-
rides was assembled either by the enzymatic cleavage of poly-
saccharides followed by purification of constituent oligosac-
charides or by chemical synthesis (Fig. 1, upper panel). Each
structure shown in Fig. 1, upper panel has been assigned a code
number (bolded to distinguish them from reference numbers),
which is consistent throughout the text. Some of the oligosac-
charides have been previously described, whereas four chemi-
cally synthesized galactosyl oligosaccharides were newly
produced (structures 19, 20, 21, and 22). Details of all oligosac-
charides are provided in supplemental Table 1. The purities of
the oligosaccharides were determined by a variety of methods
that have been described previously and referenced in supple-
mental Table 1. The purity of oligosaccharides produced from
polysaccharides was generally at least 90%, and for chemically
synthesized oligosaccharides, it was 99%. Oligosaccharides
were coupled to BSA by reductive amination with sodium cya-
noborohydride, which produced a ring-opened sugar residue
between the oligosaccharide and the BSA (Fig. 1, lower panel).
MALDI-TOFMS analysis of 20 selected neoglycoproteins indi-
cated that on average 8.4 oligosaccharides were attached to
each BSA molecule (supplemental Table 2).
Construction and Reproducibly of Oligosaccharide Micro-
arrays—Several types of substrate surfacewere tested including
a range of surface-treated glass slides (Fig. 2, A–C), glass slides
coated with nitrocellulose (Fig. 2, D and E), and nitrocellulose
membrane (Fig. 2, F–H). Two types of spotting robotwere used,
one piezoelectric (Arrayjet Sprint, Fig. 2, A–F) and one pin-
based (MicroGrid II, Fig. 2, G and H). The test prints shown
were made using BSA conjugated with (134)--D-manno-
hexaose and (135)--L-arabinopentaose printed in sextuplet
and at 10 concentrations from 2 mg/ml to 7.6 ng/ml (Fig. 2,
A–H). The arrays were probed with the anti-mannan or anti-
arabinan mAbs LM21 and LM6, respectively. The oligosaccha-
rides were successfully presented for recognition on all the sur-
faces used, but there were differences in detection limits and
spot morphologies. Of the glass slides, the nitrocellulose-
coated Nexterion E slide (Fig. 2D) and the FAST Slide (Fig. 2E)
yielded the most sensitive detection (2 g/ml for (134)--D-
mannohexaose), and the least sensitive detection was obtained
using the Nexterion P slide (125 g/ml for (134)--D-manno-
hexaose) (Fig. 2C). Although similar in detection limits, arrays
produced on the FAST Slide (Fig. 2E) were superior to those
produced on the Nexterion E slide because they had a more
consistent spot size across the concentration range, and this is
an important consideration when quantifying spot signals.
Nitrocellulose membrane was also a suitable substrate for
microarray production using both the pin-based and the piezo-
electric printers. With the piezoelectric Arrayjet printer, the
detection limit on nitrocellulose was 122.1 ng/ml (Fig. 2F), and
using the pin-based printer, the detection limit was 2g/ml for
split pins (Fig. 2G) and 0.5 g/ml for solid pins (Fig. 2H). These
data demonstrated that the neoglycoprotein oligosaccharides
are a versatile resource for the manufacture of microarrays on
diverse surfaces. The reproducibility of microarrays produced
on the piezoelectric Arrayjet robot was tested by producing 12
separate copies of arrays both on nitrocellulosemembrane (Fig.
2I) and on slides (Fig. 2J), probing with selected antibodies, and
then quantifying the spot signals from these replicate experi-
ments (Fig. 2, I and J). For both nitrocellulose and slides, six
arrayswere probedwith the anti-mannanmAbsLM21, sixwere
probed with the anti-arabinan mAb LM6, and mean spot sig-
nals from three arrays were compared with the corresponding
three replicate arrays. The data sets were plotted against each
other, and r2 values were calculated (Fig. 2, I and J). In all cases,
there was a low level of variability in the arrays, with r2 values of
greater than 0.9 in all cases. Similarly high levels of reproduc-
ibility have been previously reported for arrays produced using
the pin-based MicroGrid robot (32).
Most of the applications envisaged for oligosaccharide
microarrays involve the interrogation of arrayed samples by a
number of different glycan-binding proteins, ligands, or
enzymes, which must be kept separate during probing. To
achieve this, we designed our array production to be compatible
withmultipad slides that fit into a probing apparatus that forms
a seal around each pad. An example of a typical array setup used
is shown in supplemental Fig. 1A, where each of the 16 pads on
each slide accommodates at least 324 spots in an area 6 6mm,
OligosaccharideMicroarrays for Plant Glycobiology
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and each oligosaccharide is usually represented by four spots
(two replicates at two different concentrations). As shown in
supplemental Fig. 1B, the probing apparatus accommodates
four such slides so that in a single probing experiment, 64 dis-
tinctmAbs, CBMs, etc. can be individually screened simultane-
ously against at least 80 oligosaccharides printed in quadruplet.
50l of probing solution is required to probe one of the 16 pads.
The composite image in supplemental Fig. 1C shows the bind-
ing of five different mAbs to their respective epitopes on mul-
tiple copies of the array shown in supplemental Fig. 1A.
Specificity Screening of Monoclonal Antibodies—We tested
the microarrays for mAb screening by probing microarrays
with a selection of 38 mAbs, some with previously well charac-
terized specificities and some with new specificities (Fig. 3).
Examples of representative arrays are shown in Fig. 3A. The
heat map shown in Fig. 3B is an overview of the whole data set,
and the expanded heatmaps (Fig. 3,C–J) providemore detailed
information about the binding of selected mAbs. Oligosaccha-
ride structures are only shownwhere binding produced amean
spot signal of at least 15% of the highest mean signal in the
entire data set.
Themicroarray profiles obtained formAb bindingwere con-
sistent with data previously obtained by other techniques. For
example, mAbs LM5 (34) and LM6 (35) bound predominantly
to (134)--D-galactan (structure 19) and (135)--L-arabin-
ans (structures 9, 10, 11, 12, 13, and 14) respectively (Fig. 3C).
As previously shown (39), mAbs LM21 and LM22 bound to
mannan-containing oligosaccharides, and LM22, but not
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FIGURE 1. A library of plant oligosaccharides. Upper panel, structures 1–6, 19, 20, 21, 22, and 72 were chemically synthesized, whereas all other oligosac-
charideswere produced by fractionation of polysaccharides followed by separation and purification. The oligosaccharides are shown after coupling to BSA by
reductive amination as shown in the lower panel.  glycosidic linkages are indicated by the small  symbols on the structures, and all other linkages are . The
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of the oligosaccharides are provided in supplemental Table S1. Note that the structures illustrated in this figure correspond to those listed in supplemental
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LM21, bound strongly to galactomannan-derived oligosaccha-
rides (structures 32, 33, and 34) (Fig. 3D). The inclusion of
oligosaccharides with different degrees of polymerization pro-
vided information about the epitope sizes recognized by some
mAbs. For example, LM6 bound strongly to an arabinan dimer
(structure 9) and similarly to arabinans with degrees of polym-
erization up to 7 (Fig. 3C). In contrast, LM13 binding was
restricted to longer oligosaccharides, and LM13 did not bind to
an arabinan dimer (structure 9) and only very weakly to an
arabinan trimer (structure 10), confirming and extending the
previous analysis of the recognition of soluble oligosaccharides
by competitive inhibition ELISAs (36) (Fig. 3C). Similarly,
although LM22 (39) bound strongly to a mannan dimer (struc-
ture 27), mAbBS-400-4 (43) did not, and theminimum epitope
size for this mAb appears to be at least 3 degrees of polymeri-
zation (Fig. 3D). LM12, a novel rat mAb derived subsequent to
immunization with a feruloylated arabinosyl-BSA immunogen,
displayed recognition of feruloyl residues attached to a range of
sugars (Fig. 3F). In contrast to the previously described LM9,
which is specific to feruloylated galactan (44), LM12 bound to
oligosaccharides containing feruloylated arabinosyl residues
(structures 15 and 16) aswell as feruloylated galactosyl residues
(structure 24) (Fig. 3F). The anti-RGI mAb LM16 bound with
greatest avidity to a new synthetic galactotriose (structure 21)
(Fig. 3F) and also showed unexpected binding to hexaamino-
(134)--D-glucohexaose (structure 78, Fig. 3I), although this
cross-reactivity is unlikely to present problems for plant
research because this polymer is unknown in the plant king-
dom. A novel aldouronic acid epitope (glucoronyl-(132)--
(134)--D-xylotriose, structure 42) recognized by anti-arabi-
nogalactan protein (AGP) mAbs, LM14 and JIM14, was also
identified (Fig. 3G). As expected, the anti-(133),(134)--D-
glucan mAb BS-400-3 bound to the (133),(134)--D-glucan
structures 65 and 66 and did not cross-react with the (133)-
-D-glucan oligosaccharides 57, 58, and 59 (45), and the anti-
(133)--D-glucan mAb BS-400-2 also showed its expected
binding to -glucans containing 1,3-linkages (46) (Fig. 3H).
mAb JIM6 showed broad specificity for -glucans containing
FIGURE 2.Microarray printing surfaces and reproducibility. Coupling oligosaccharides to protein enabled printing on a wide variety of slides and mem-
branes commonly used formicroarrayproduction. (134)--D-Mannohexaose and (135)--L-arabinopentaosemicroarrayswereprinted in sextuplet andat 10
concentrations from 2 mg/ml to 30.5 ng/ml. The arrays were probed with the anti-mannan or anti-arabinan monoclonal antibodies LM21 and LM6, respec-
tively. Microarrays were printed using a noncontact piezoelectric robot (A–F) or a pin-based robot (G and H). Arrays were printed on surface-modified glass
slides (A–C), nitrocellulose-coatedglass slides (D and E), andnitrocellulosemembrane (F–H). Reproducibility of themicroarrayswas testedbyprinting12 copies
of arrays on both nitrocellulose membrane (I) and nitrocellulose-coated glass FAST Slides (J). Arrays were probed with the anti-mannan mAbs LM21 or the
anti-arabinanmAbLM6. Representative probed replicate arrays are shown, aswell as graphs ofmean spot signals from three arrays plotted against each other.
Axes on the graphs are relative mean spot signals.
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1,4-linkages but did not bind to -glucans containing 1,3-link-
ages (Fig. 3H).
Five antibodies directed to xyloglucan displayed subtle dis-
tinctions in recognition of xyloglucan-derived oligosaccharides
with novelmAbs LM24 and LM25 displayingwider recognition
of galactosylated xyloglucan oligomers (and in the case of LM25
weak binding to unsubstituted -glucan) than the previously
characterized mAb LM15 (38) (Fig. 3J). The differences in the
anti-xyloglucan mAb array binding profiles were reflected in
differing binding profiles when applied to pectate lyase-treated
transverse sections of tobacco stem pith parenchyma as shown
in Fig. 4. Previous work had demonstrated that after pectic
homogalacturonan removal, the LM15 xyloglucan epitope is
revealed abundantly at the corners of intercellular spaces (Mar-
cus et al. (38)) (Fig. 4B). In equivalent material, the LM24
epitope wasmost abundant in adhered cell walls between inter-
cellular spaces (Fig. 4C), and the LM25 epitope was localized in
cell walls lining intercellular spaces (Fig. 4D).
Specificity Screening of CBMs—We tested the oligosaccha-
ride microarrays for CBM screening by probing arrays with a
set of CBMs that were produced by mutation of CBM4-2 from
Rhodothermus marinus (47–49) and with a variety of lectins
(Fig. 5). Wild type CBM4-2 is a xylan-binding CBM, and as
expected, it bound to xylobiose (structure 38), xylotriose
(structure 39), xylotetraose (structure 40), and xylopentaose
(structure 41) (Fig. 5). CBM4-2 has also been reported to cross-
react with certain (133)(134)--D-glucans, and semiquanti-
tative affinity electrophoresis indicated a similar level of
binding of CBM4-2 to birch xylan as to barley (133),(134)--
D-glucan (50). The array data were in agreement with this
because in addition to the xylan oligosaccharides, CBM4-2 also
bound to (133),(134)--D-glucotetraose and (133),(134)-
FIGURE 3.Specificity screeningofmAbs.Oligosaccharidemicroarrayswere probedwith a set of 38monoclonal antibodies, and selected examples of probed
arrays are shown in A. Themean spot signals obtained from three experiments are presented in heatmaps in which color intensity is correlated to signal (B–I).
Expanded heatmaps (C–I) providemore detailed information about the binding of selectedmAbs. The highest signal in the entire data set was set to 100, and
all other values were normalized accordingly. Oligosaccharide structures are only shown where binding produced a mean spot signal of at least 15% of the
highest mean signal in the entire data set. Further details about the oligosaccharides are provided in supplemental Table S1.
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-D-glucopentaose (structures 65 and 66), but its much weaker
binding to (133),(134)--D-glucotriose (structure 62) pro-
vides insight into the minimum degrees of polymerization
required for optimal binding. X-6 showed a greater specificity
for xylan oligosaccharides than CBM4-2 and bound with great-
est avidity to xylopentaose (structure 41) and xylotetraose
(structure 40) and weakly to xylotriose (structure 39). X-6
appears to have a requirement for at least three xylose residues
for binding because it did not bind to xylobiose (structure 38).
A-12 showed a similar specificity to X-6 but also cross-reacted
with the linear (134)--linked glucopentose (structure 54).
A-8 displayed an even more restricted binding profile to xylan
oligomers than X-6 and bound strongly to xylopentaose (struc-
ture 41) but only weakly to xylotetraose (structure 40). The
mutant CBMs M60-3 and MRT-5 also bound to the xylopen-
taose (structure 41), and MRT-5, but not M60-3, bound to the
xylotetraose (structure 40). However, both CBMs had new
cross-reactivities when compared with wild type CBM4-2 and
bound to xyloglucan oligosaccharides (structure45) and (struc-
ture 46). The binding toMRT-5 appeared to be inhibited by the
presence of galactose because this CBM bound only weakly to
structure 46 but strongly to structure 45, which is identical
apart from the galactose substitution of one xylose residue.
Together, these data indicate that oligosaccharide microarrays
are useful tools for the rapid screening of the binding profiles of
CBMs. However, in contrast to most antibodies, CBMs often
display moderate binding affinities, and this may limit the
application of these arrays for some CBM studies.
Competitive Inhibition Assays—One potential concern of
assays based on immobilized targets is that the binding of anti-
bodies, CBMs, or other probes might be either inhibited or
promoted by the immobilization itself or by the coupling of the
oligosaccharides to the carrier molecule, in this case BSA. To
test for this, we also used the arrays in a competitive inhibition
format whereby arrays were probed in the presence of soluble
unconjugated oligosaccharides used at a range of concentra-
tions (supplemental Fig. 2). A set of mAbs and CBMs was
tested, and in all cases, the results obtainedwere consistentwith
those obtained using immobilized neoglycoproteins. For exam-
ple, the binding of the anti-AGP LM14 to glucoronyl-(132)--
(134)--D-xylotriose-BSA was inhibited by the unconjugated
version of this structure but not by -(134)-D-xylotetraose
(structure 39). Similarly, the binding of CBM4-2 to both
(134)--D-xylotriose-BSA and 3--D-glucosyl-(134)--D-
glucobiose-BSA was inhibited by unconjugated (134)--D-
xylohexaose, and the binding of mAbs LM21 and LM22 was
inhibited by appropriate haptens (supplemental Fig. 2).
Oligosaccharide Microarrays as Multiplexed Acceptors for
Enzyme Assays—Microarrays of immobilized sets of substrates
or acceptors are potentially useful tools for HTP enzyme
screening and characterization that enablemultiplexed analysis
of activities. Arrays of polysaccharides (51) and limited num-
bers of oligosaccharides (52) have been used to explore glyco-
syltransferase activities, and we were interested to test the
applicability of our arrays for similar purposes. As proof of con-
cept, we tested rabbit muscle phosphorylase using [14C]glucose
1-phosphate as the glycosyl donor (Fig. 6). The general mecha-
nism of the method is shown in Fig. 6A. Scanning the arrays
with a PhosphorImager after incubation with enzyme and gly-
cosyl donor revealed specific 14C-labeled spots representing the
transfer of [14C]glucose onto -linked glucan oligosaccharides
that were present on this particular microarray (structures 67,
69, and 71) (Fig. 6B). A control array that had been treated with
enzyme inactivated by boiling did not show incorporation of
[14C]glucose (Fig. 6C).
FIGURE 4. Localizationof xyloglucan epitopes in tobacco stems. Immuno-
fluorescence imaging of transverse sections of tobacco stem pith paren-
chyma cell walls with anti-xyloglucanmAb after a pectate lyase pretreatment
is shown.A, Calcofluor fluorescence showing all cell walls. B, the same section
as A with immunofluorescence labeling with mAb LM15 showing abundant
binding to cell walls at the corners of intercellular spaces (*). C, equivalent
section showing immunofluorescence labeling with mAb LM24 indicating
most abundant labeling in regions of adhered cell walls between intercellular
spaces. D, equivalent section showing immunofluorescence labeling with
mAb LM25, which binds abundantly to cell walls lining intercellular spaces.
Scale bars 10 m.
FIGURE 5. Specificity screening of carbohydrate-binding modules and
lectins. Oligosaccharide microarrays were probed with the xylan-binding
CBMCBM4-2 and alsomutant variants of CBM4-2: XG-34/1-X; XG-34/2-VI; X-6;
X-13; M60-3; MRT-5; A-8; and A-12. The highest signal in the entire data set
was set to 100, and all other values were normalized accordingly. Further
details about the oligosaccharides are provided in supplemental Table S1.
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DISCUSSION
It is generally recognized that there is a widening gap
between our ability to discover genes and proteins and to
understand their roles in plant glycobiology. For example, it is
estimated that we can safely predict the activities of no more
than 20% of the proteins within the CAZy database (11). We
show here that carbohydrate microarrays can make a valuable
contribution to the HTP analysis of a variety of carbohydrate-
protein interactions, and although oligosaccharidemicroarrays
have been described for use in medical animal and microbial
research, equivalent technology has not previously been devel-
oped for plant research.
The use of defined oligosaccharides rather than polysaccha-
rides is important for obtaining detailed information about car-
bohydrate-interacting proteins. A library of cell wall-derived
oligosaccharides is a significant resource in itself, and once cou-
pled to protein, it can be used to produce microarrays on
diverse surfaces. The versatility of being able to print microar-
rays on both nitrocellulose and slides is important. Although
slide-based microarrays can only be analyzed using specialized
scanning equipment, membrane-based arrays can be used by
non-experts and scanned using an ordinary office scanner and
are thus ideal for wider distribution to researchers. Several link-
ers have been developed for the covalent and noncovalent
attachment of oligosaccharides to substrates. For example, cou-
pling to lipids has also been shown to be a highly effective
method for oligosaccharide microarray production (19, 20, 25,
26, 53). One reason for choosing BSA as a carrier molecule was
because BSA-based neoglycoproteins are a multifunctional
resource that can be used not just for microarray production
but also as immunogens and as components of other assays for
which immobilization is required. Nevertheless, any coupling
procedure that involves modification of reducing ends is likely
to interfere with the activity of reducing end-acting probes or
enzymes, and this may be exacerbated by the large size of the
BSA molecule. We found that BSA-coupled oligosaccharides
arrayed as described previously (see “Experimental Proce-
dures”) were effective substrates for several exo-acting glycosyl
hydrolases but not for endo-acting enzymes (data not shown).
Presumably, the exo-acting enzymes were nonreducing-end
acting, and the lack of activity of the endo-acting enzymeswas a
result of steric hindrance from the BSA.
This study highlighted some important technical aspects of
oligosaccharide microarray production including the relative
merits of different microarray robot printers. The pin-based
MicroGrid II printer was suited for the production of microar-
rays on nitrocellulose membrane with larger spot sizes. How-
ever, we found that array quality often decreased with longer
print runs such that some spots were missing or not properly
printed, and this is likely to result from the inevitable wear of
the pins that occurs with contact printing. This drawback is
avoided with noncontact printers such as the Arrayjet Sprint
that dispel samples by a highly reproducible piezo-actuation
process. Another major advantage of the Arrayjet Sprint is its
much greater speed, which is important not just to increase
throughput but because the evaporation of sample buffer with a
concomitant concentration of samples can be highly problem-
atic during longmicroarray print runs. Importantly, by printing
arrays on multipad slides (as shown in supplemental Fig. S1),
such that each pad is isolated by a gasket during probing, it is
possible to simultaneously assess the binding of large numbers
of mAbs, CBMs, etc. against many immobilized samples. For
example, using ten 16-pad slides, it is possible to simultane-
ously screen 160 antibodies, each against 400 immobilized
glycans.
The primary goal of this work was to develop plant oligosac-
charidemicroarray technology per se, but we also obtained new
epitope-level information about mAb specificities. For exam-
ple, mAbs LM14 and JIM14 have previously been described as
binding to unknown epitopes occurring on AGPs (32, 54). The
oligosaccharide microarrays demonstrated that both mAbs
bind with high specificity to glucoronyl-(132)--(134)--D-
xylotriose (structure 42) (Fig. 3G), which is a constituent of
glucoronoxylan and glucoronoarabinoxylans, and this finding
is therefore interesting because it implies that these two mAbs
may bind to an epitope not usually associated with AGPs in
addition to binding to glucoronyl residues decorating arabi-
nogalactan structures. The synthetic galactosyl structures 20,
FIGURE 6. Oligosaccharide microarrays as multiplexed acceptors for
enzyme assays. A, schematic showing the experimental setup used to assay
the activity of rabbitmuscle phosphorylase using a [14C]glucose 1-phosphate
donor and an array of immobilized oligosaccharide acceptor. B, an oligosac-
charidemicroarraywasused to assay the activity of rabbitmusclephosphory-
lase a with [14C]glucose 1-phosphate as a glycosyl donor. The incorporation
of 14C was detected using a PhosphorImager system. The control array in
C was probed with boiled phosphorylase a under the same conditions. The
structures of the oligosaccharides that were themost effective acceptors are
shown. Further details about the oligosaccharides are provided in supple-
mental Table S1.
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21, and 22 are not known to occur on any plant cell wall poly-
saccharide, and it was therefore surprising that mAb LM16
bound strongly to 6--D-galactosyl-(134)--D-galactotriose
(structure 21). LM16 has been described previously as binding
to an epitope occurring on sugar beet RGI that is generated by
arabinofuranosidase treatment and is galactosidase-labile (36).
Sugar beet arabinan side chains can in some cases be attached
to RGI backbones via short galactosyl motifs, and it is possible
that LM16 recognizes this structure once exposed by arabino-
furanosidase (36). It has been shown that such short galactan
stubs can be substituted with ferulic acid at the C6 position, but
substitution with another sugar has not been reported (55).
LM16 does not bind to galactosyl residues per se because it does
not bind to linear galactan, galactomannan, or galactoxyloglu-
cans. The strong binding of LM16 to both structure 21 and
native sugar beet pectin therefore raises the intriguing possibil-
ity of a novel RGI epitope.
The importance of obtaining detailed information about
epitope structures was clearly illustrated by the anti-xyloglucan
mAbs LM15, LM24, and LM25. Oligosaccharide array analysis
revealed subtle differences in the binding profiles of these
mAbs, which most likely would not have been discriminated
using previous polysaccharide-based ELISA or microarrays.
Immunolabeling of tobacco sections with these mAbs showed
that despite their relatively small differences in structure, the
epitopes recognized had distinct cellular locations. Although
the biological significance of these findings is unclear at pres-
ent, they show that a detailed evaluation of epitope structures
that oligosaccharide arrays can provide is important for the
subsequent interpretation of data produced in antibody studies.
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SUPPLEMENTAL MATERIAL 
 
 
 SUPPLEMENTARY TABLE 1 
 
Code 
number1 
Oligosaccharide2 Purity3 Production 
method4 
Starting 
material 
Reference5 
1 6’,6’’’,6’’’’’-trimethyl-(1→4)-α-D-hexagalacturonic 
acid  
>99% Synthesis D-galactose Clausen et al. 
2 6’,6’’,6’’’,6’’’’-tetramethyl-(1→4)-α-D-
hexagalacturonic acid 
>99% Synthesis D-galactose Clausen et al. 
3 6’,6’’’’’-dimethyl-(1→4)-α-D-hexagalacturonic acid >99% Synthesis D-galactose Clausen et al.  
4 6’,6’’,6’’’-trimethyl-(1→4)-α-D-hexagalacturonic 
acid 
>99% Synthesis D-galactose Clausen et al. 
5 6,6’’’’,6’’’’’-trimethyl-(1→4)-α-D-hexagalacturonic 
acid 
>99% Synthesis D-galactose Clausen et al. 
6 (1→4)-α-D-hexagalacturonic acid >99% Synthesis D-galactose Clausen, M.H. 
7 4’’’’’’- (4,5-anhydro-α-D-galacturonyl)- (1→4)-α-D-
octagalacturonic acid 
>99% Enz. F.&P. Polygalacturoni
c acid, lime  
Guillaumie et 
al. 
8 (1→5)-α-L-arabinobiose ~95% Enz. F.&P. de-branched 
arabinan, sugar 
beet 
Megazyme 
9 (1→5)-α-L-arabinotriose ~95% Enz. F.&P. de-branched 
arabinan, sugar 
beet 
Megazyme 
10 (1→5)-α-L-arabinotetraose ~95% Enz. F.&P. de-branched 
arabinan, sugar 
beet 
Megazyme 
11 (1→5)-α-L-arabinopentaose ~95% Enz. F.&P. de-branched 
arabinan, sugar 
beet 
Megazyme 
12 (1→5)-α-L-arabinohexaose ~95% Enz. F.&P. de-branched 
arabinan, sugar 
beet 
Megazyme 
13 (1→5)-α-L-arabinoheptaose ~95% Enz. F.&P. de-branched 
arabinan, sugar 
beet 
Megazyme 
14 (1→5)-α-L--arabinooctaose ~95% Enz. F.&P. de-branched 
arabinan, sugar 
beet 
Megazyme 
15 2’-E-feruloylyl-α-(1→5)-L-arabinofuranobiose >98% Enz. F.&P. Sugar beet pulp Ralet et al 
1994 
16 2’-E-feruloylyl-α-(1→5)-L-arabinofuranotriose >98% Enz. F.&P. Sugar beet pulp Ralet et al 
1994 
17 D-galactose  >99% na  na  Sigma-
Aldrich 
18  (1→4)-β-D-galactobiose ~90% Enz. F.&P. Galactan  Megazyme 
19  (1→4)-β-D-galactotetraose >99% Synthesis D-galactose Clausen, M. 
H.  
20 6’-α-D-galactosyl- (1→4)-β-D-galactotriose >99% Synthesis D-galactose Clausen, M. 
H. 
21 6’-β-D-galactosyl- (1→4)-β-D-galactotriose >99% Synthesis D-galactose Clausen, M. 
H. 
22 4’,6’-α-D-digalactosyl- (1→4)-β-D-galactobiose >99% Synthesis D-galactose Clausen, M. 
H. 
23 β-D-galactosyl-(1→4)-D-glucose (lactose, milk sugar) >99% na  na  Sigma-
Aldrich 
24 6’-E-feruloylyl- (1→4)-β-D-galactobiose >98% Enz. F.&P. Sugar beet 
galactan 
Ralet et al 
1994 
25 D-Mannose >99% na  na  Sigma-
Aldrich 
1
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26 (1→4)-β-D-mannobiose ~95%  Enz. F.&P. Mannan Megazyme 
27 (1→4)-β-D-mannotriose ~95% Enz. F.&P. Mannan Megazyme 
28 (1→4)-β-D-mannotetraose ~95% Enz. F.&P. Mannan Megazyme 
29 (1→4)-β-D-mannopentaose >95% Enz. F.&P. Mannan Megazyme 
30 (1→4)-β-D-mannohexaose >95% Enz. F.&P. Mannan Megazyme 
31 6-α-D-galactosyl- (1→4)- 
 β-D-mannobiose 
~95% Enz. F.&P. galactomannan, 
carob 
Megazyme 
32 6-α-D-galactosyl- (1→4)- 
 β-D-mannotriose 
>95% Enz. F.&P. galactomannan, 
carob  
Megazyme 
33 Galman VF ~95% Enz. F.&P. galactomannan, 
carob  
Farkas, V.  
34 6’’,6’’’-α-D-digalactosyl- (1→4)-β-D-mannopentaose ~95% Enz. F.&P. galactomannan, 
carob 
Megazyme 
35 Glcman 1 ~95% Enz. F.&P. Konjac Farkas, V.  
36 Glcman 2 ~95% Enz. F.&P. Barley Farkas, V. 
37 (1→4)-β-D-xylobiose >95% A.hyd. F.&P. arabinoxylan Megazyme 
38 (1→4)-β-D-xylotriose >95% A.hyd. F.&P. arabinoxylan Megazyme 
39 (1→4)-β-D-xylotetraose >95% A.hyd. F.&P. arabinoxylan Megazyme 
40 (1→4)-β-D-xylopentaose >95% A.hyd. F.&P. arabinoxylan Megazyme 
41 (1→4)-β-D-xylohexaose >95% A.hyd. F.&P. arabinoxylan Megazyme 
42 D-glucoronyl-α-(1→2)-[ (1→4)-β-D-xylotriose] 
(aldouronic acid)  
~95% Enz. F.&P. arabinoxylan Megazyme 
43 L-arabinosyl-α-(1→2)-[(1→4)-β-D-xylobiose] ~95% Enz. F.&P. Xyloglucan Megazyme 
44 β-D-xylosyl-(1→6)-D-glucose (isoprimeverose) ~95% Enz. F.&P. Xyloglucan Megazyme 
45 β-X-(1→4)-β-X-(1→4)-β-X-(1→4)-G (xyloglucan 
heptamer) 
~90% Enz. F.&P. Xyloglucan Megaxyme 
46 β-X-(1→4)-β-L-(1→4)-β-X-(1→4)-G (xyloglucan 
octamer) 
~90% Enz. F.&P. Xyloglucan Farkas & 
Maclachlan 
1988 
47 β-L-(1→4)-β-L-(1→4)-β-X-(1→4)-G (xyloglucan 
nonamer) 
~90% Enz. F.&P. Xyloglucan Farkas & 
Maclachlan 
1988 
48 XXXGXXXG ~80% Enz. F.&P. Xyloglucan Megazyme 
49 D-glucose >99.5% na  Biomass Sigma-
Aldrich 
50 (1→4)-β-D-glucobiose (cellobiose) ≥98% na  na  Sigma-
Aldrich 
51 (1→4)-β-D-glucotriose (cellotriose) ~95% A.hyd. F.&P. Cellulose 
acetate 
Megazyme 
52 (1→4)-β-D-glucotetraose (cellotetraose) ~95% A.hyd. F.&P. Cellulose 
acetate 
Megazyme 
53 (1→4)-β-D-glucopentaose (cellopentaose) ~94% A.hyd. F.&P. Cellulose 
acetate 
Megazyme 
54 (1→4)-β-D-glucohexaose (cellohexaose) ~94% A.hyd. F.&P. Cellulose 
acetate 
Megazyme 
55 (1→3)-β-D-glucobiose (laminaribiose) ~95% A.hyd. F.&P. Curdlan  Megazyme 
56 (1→3)-β-D-glucotriose (laminaritriose) ~95% A.hyd. F.&P. Curdlan Megazyme 
57 (1→3)-β-D-glucotetraose (laminaritetraose) ~95% A.hyd. F.&P. Curdlan Megazyme 
58 (1→3)-β-D-glucopentaose (laminaripentaose) ~95% A.hyd. F.&P. Curdlan Megazyme 
59 (1→3)-β-D-glucohexaose (laminarihexaose) ~95% A.hyd. F.&P. Curdlan Megazyme 
60 3’-β-D-glucosyl- (1→4)-β-D-glucobiose >95% Enz. F.&P. β-glucan 
(barley) 
Megazyme 
61 4’-β-D-glucosyl- (1→3)-β-D-glucobiose 95% Enz. F.&P. β-glucan 
(barley) 
Megazyme 
62 3’-β-D-glucosyl- (1→4)-β-D-glucotriose ~90% Enz. F.&P. β-glucan 
(barley) 
Megazyme 
63 3-β-[(1→4)-β-D-glucotriosyl]-D-glucose  95% Enz. F.&P. β-glucan 
(barley) 
Megazyme 
64 3’-β-[ (1→4)-β-D-glucobiosyl]- (1→4)-β-D-
glucobiose 
~90% Enz. F.&P. β-glucan 
(barley) 
Megazyme 
65 Mlg5a ~90% Enz. F.&P. β-glucan 
(barley) 
Megazyme 
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66 Mlg6a ~90% Enz. F.&P. β-glucan 
(barley) 
Megazyme 
67  (1→4)-α-D-glucobiose (maltose) ≥98% na  Potato Sigma-
Aldrich 
68 (1→4)-α-D-glucotriose (maltotriose) 95% na  na  Sigma-
Aldrich 
69 (1→4)-α-D-glucohexaose (maltohexaose) ≥98% na   na  Sigma-
Aldrich 
70 6’’-α-D-glucosyl- (1→4)-α-D-glucotriose ~95% Enz. F.&P. Pullulan Megazyme 
71 6’’-α-{6**-α-D-glucosyl-[ (1→4)-α-D-glucotriosyl]}- 
(1→4)-α-D-glucotriose 
~95% Enz. F.&P. Pullulan Megazyme 
72 6’,6’’’’-α-di-[ (1→4)-α-D-glucobiosyl]- (1→4)-α-D-
glucohexaose 
>99% Synthesis D-glucose Damager et 
al. 
73 N-Acethyl-2-deoxy-2-amino-D-glucose  >95% na   na  Sigma-
Aldrich 
74 N,N’-diacethyl-2,2’-dideoxy-2,2’-diamino- (1→4)-β-
D-glucobiose 
~95% Acid 
hydrol/frac 
Chitin Megazyme 
75 N,N’,N’’-triacethyl-2,2’,2’’-trideoxy-2,2’,2’’-
triamino- (1→4)-β-D-glucotriose 
~95% Acid 
hydrol/frac 
Chitin Megazyme 
76 N,N’,N’’,N’’’-tetraacethyl-2,2’,2’’,2’’’-tetradeoxy-
2,2’,2’’,2’’’-tetraamino- (1→4)-β-D-glucotetraose 
~95% Acid 
hydrol/frac 
Chitin Megazyme 
77 N,N’,N’’,N’’’,N’’’’-pentaacethyl-2,2’,2’’,2’’’,2’’’’-
pentadeoxy-2,2’,2’’,2’’’,2’’’’-pentaamino- (1→4)-β-
D-glucopentaose 
~95% Acid 
hydrol/frac 
Chitin Megazyme 
78 N,N’,N’’,N’’’,N’’’’,N’’’’’-hexaacethyl-
2,2’,2’’,2’’’,2’’’’,2’’’’’-hexadeoxy-
2,2’,2’’,2’’’,2’’’’,2’’’’’-hexaamino- (1→4)-β-D-
glucohexaose 
~95% Acid 
hydrol/frac 
Chitin Megazyme 
1
 Oligosaccharides are numbered according to figure 2. 
2
 Oligosaccharide name refers to the structure 
of the unconjugated glycan i.e. the reducing end sugar residue is intact. 
3
 Purities are determined by 
the suppliers and are approximate percentages. Production methods: Synthesis, chemical synthesis 
from monosaccharides; Enz. F.&P, enzymatic digestion followed by fractionation and purification; 
A.hyd. F.&P., acidic hydrolysis followed by fractionation and purification; na, data not available. 
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                   SUPPLEMENTARY TABLE 2 
 
Conjugate 
no 
(see Table 
S1) 
Mass of the 
oligosaccharide 
(g/mol) 
Mass of the 
conjugate 
(m/z) 
Average 
no. of 
residues 
on BSA 
42 511.23 69,078.9 4.67 
10 546.56 71070.6 8.01 
14 1075,20 73099.1 5.96 
52 666.58 74843.4 12.23 
54 828.72 79909.4 15.95 
76 830.80 69035.6 2.82 
18 342.30 69567.7 8.40 
32 666.58 71927.0 7.85 
57 666.58 67798.9 1.66 
67 342.30 71672.3 14.54 
- 513.23 70577.7 7,57 
70 666.58 73033.4 9.51 
69 828.72 78212.2 13.90 
72 1639,44 69938.9 1.98 
63 666.58 69037.1 3.52 
28 666.58 72060.6 8.05 
30 828.72 73395.0 8.09 
39 546.56 72614.9 10.83 
45 1061.92 82198.2 14.60 
48 2105.82 68557,7 0.89* 
 
 
 
SUPPLEMENTARY FIGURE LEGENDS 
 
SUPPLEMENTARY FIGURE 1.  Microarray layout and handling.  (A) A typical oligosaccharide 
microarray printed using a piezoelectric robot onto a 16-pad nitrocellulose-coated glass slide. Each of 
the 16 pads is 6 x 6 mm and can accommodate approximately at least 324 spots. Typically, each 
oligosaccharide is represented by 4 spots (two replicates of two concentrations). (B) Multi-chamber 
incubation equipment is crucial for high throughput analysis. In this example, 64 arrays can be probed 
separately and simultaneously. (C) A composite image showing five identical arrays with the layout 
shown in (A) and probed with five monoclonal antibodies (mAbs): mAb LM6 (anti-(1→5)-α-L-
arabinan); mAb LM10 (anti-(1→4)-β-D-xylan); mAb LM15 (anti-xyloglucan); mAb LM24 (anti-
xyloglucan); mAb BS-400-2 (anti-(1→3)-β-D-glucan). 
 
SUPPLEMENTARY FIGURE 2.  Competitive inhibition studies. The binding of selected 
monoclonal antibodies  (mAbs) and carbohydrate binding modules (CBMs) to selected 
oligosaccharides was tested by competitive inhibition binding studies in which micoarrays were 
probed with in the presence of un-conjugated oligosaccharides. (A) Examples of competitive 
microarray assays. Binding of the xylan-binding CBM4-2 and the anti-AGP mAb LM14 to 
immobilized glycan were inhibited by 2 mg-mL (1→4)-β-D-glucotetraose (structure 52) and 
glucoronyl- (1→2)-α-[ (1→4)-β-D-xylotriose] (Structure 42) respectively, whilst LM14 binding was 
not inhibited by (1→4)-β-D-xylotetraose. (B) Heatmap showing the inhibitory effects of several 
haptens used from 0 to 10 mg/mL on the binding of mAbs LM14, LM21 (anti-mannan) and LM22 
(anti-mannan/galactomannan). The structures of haptens and immobilised glycans are as listed in 
Supplementary Table 1. 
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Supplemental Figure S1
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5
Probe: LM14 
Hapten: 42 
No Hapten 
Hapten 
 (mg/mL) 
Probe: CBM4-2 
Hapten: 52 
Probe: LM14 
Hapten: 39 
Hapten concentraction (mg/ml) 
Hapten Immob. glycan Probe 10 2 0,4 0,08 0 
76 88 100 93 90 39 42 LM14 
5 6 34 65 90 42 42 LM14 
19 18 31 39 59 30 30 LM21 
24 30 43 55 76 32 30 LM21 
21 30 57 73 85 34 32 LM22 
9 13 16 22 48 32 32 LM22 
25 37 56 68 97 28 32 LM22 
22 33 45 62 94 30 32 LM22 
1 1 1 2 70 41 39 CBM4-2 
0 0 3 13 70 41 62 CBM4-2 
A 
B  
Supplemental Figure S2
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